|
|
|
|
|
|
- New Chemical Entities
An integrated drug discovery and information company. The company unites three complementary technology platforms: bio-organic chemistry and drug leads from natural products; drug discovery informatics; pharmaco- and toxico-genomics.
- Interneuron Pharmaceuticals
Biopharmaceutical company engaged in the development and commercialization of a portfolio of products primarily for neurological and behavioral diseases. Lead products target panic/anxiety, overactive bladder, liver disease, prevention of HIV, etc.
- ImmunoGen
Immunogen, Inc. develops, produces, and markets commercial anti-cancer and other pharmaceutical products based on molecular immunology. Develops products that deliver chemotherapy directly to cancer cells.
- Genzyme
A highly diversified company, Genzyme uses a wide range of technologies to provide human health care products and services. Genzyme Tissue Repair, Genzyme Molecular Oncology, Genzyme Transgenics Corporation.
- Genetics Institute AA Unspecified
Our site is dedicated to being a resource for scientists, physicians, nurses, teachers, students, and all who are interested in recombinant technology, the biopharmaceutical industry or scientific acheivements.
- Geltex Pharmaceuticals
Develops and markets non-absorbed polymer drugs that bind and eliminate target substances within the gastrointestinal tract. In addition, our Company is developing small-molecule pharmaceuticals consisting of novel polyamine analogues.
- EPIX Medical
EPIX, a development stage company, engaged in the development of targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human diseases.
- Dyax
Dyax is developing and commercializing new products for the pharmaceutical and biopharmaceutical industries. Discover and develop products using Dyax' s two technology platforms - Phage Display Binding Technology and Separations Products Platform
- Curis
Developing products that define an emerging area of biotechnology known as regenerative medicine. These products are designed to recreate the conditions that support the growth of cells and tissue.
- Cubist Pharmaceuticals
Cubist Pharmaceuticals is a specialty pharmaceutical company focused on the research, development and commercialization of new antimicrobial drugs to combat serious and life-threatening bacterial & fungal infections.
- Cambridge NeuroScience
Engaged in the discovery and development of pharmaceutical products to treat severe disorders and injuries of the nervous system, including stroke, traumatic brain injury, Alzheimer' s disease and multiple sclerosis.
- Bunsen Rush
Provides receptor screening services for the pharmaceutical and biotechnology industries.
- Biopure
Biopure Corporation develops, manufactures and markets oxygen therapeutics, for both human and veterinary use, designed to serve as an alternative to red blood cell transfusions and for use in the treatment of other critical care conditions.
- Biomatrix
Biomatrix develops, manufactures and markets proprietary viscoelastic products composed of biological polymers called hylans for use in therapeutic applications and skin care.
- Biogen
One of the world's premier biotechnology companies. In 1996, Biogen introduced its first proprietary product, AVONEXr (Interferon beta-1a), and achieved its goal of becoming a fully operational global pharmaceutical company.
|
|
|
»ç¿ë»ó °ÇÀÇ»çÇ× ¹× À߸øµÈ ºÎºÐÀ̳ª
Ʋ¸° ³»¿ëÀÌ ÀÖÀ¸¸é,
¹Ù·Î ¿¬¶ôÁÖ¼¼¿ä. °¨»çÇÕ´Ï´Ù. |
|
¡¡¡¡¡¡¡¡¡¡¡¡¡¡
Help : service@kr.chemnet.com |
|
|